1-7 of 7
Sigitas Verselis, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I Trial of Maintenance Sorafenib after Allogeneic Hematopoietic Stem Cell Transplantation for Patients with FLT3-ITD AML

Free
Yi-Bin Chen, MD, Li Shuli, PhD, Lane A. Andrew, MDPhD, Christine Connolly, Candice Del Rio, NP, Betsy Valles, NP, Morgan Curtis, Karen K. Ballen, MD, Corey S Cutler, MD MPH, Bimalangshu R Dey, MD, Areej El-Jawahri, MD, Amir T. Fathi, MD, Vincent T Ho, MD, Amy Joyce, NP, Steven L. McAfee, MD, Michelle A Rudek, Trivikram Rajkhowa, Sigitas Verselis, PhD, Joseph H. Antin, MD, Thomas R. Spitzer, MD, Mark Levis, MD PhD, Robert J. Soiffer, MD
Journal: Blood
Blood (2014) 124 (21): 671.
https://doi.org/10.1182/blood.V124.21.671.671
Published: 2014
Journal Articles

Genome-Wide Aberrant Splicing in Patients with Acute Myeloid Leukemia (AML) Indetifies Potential Novel Targets

Free
Sophia Adamia, Ph.D, Michal Bar-Natan, M.D, Benjamin Haibe-Kains, Ph.D, Hervé Avet-Loiseau, MD, PhD, Laurence Lode, Ph.D, Samuel Pevzner, Sigitas Verselis, PhD, Edward Fox, PhD, Ilene Galinsky, ANP, John Quackenbush, Ph.D, Richard M. Stone, MD, James D Griffin, MD
Journal: Blood
Blood (2011) 118 (21): 761.
https://doi.org/10.1182/blood.V118.21.761.761
Published: 2011
Journal Articles

The Anti-CD20 Monoclonal Antibody GA101 Displays More Robust Anti-Tumor Activity Versus Rituximab In Waldenstrom's Macroglobulinemia (WM)

Free
Guang Yang, MD, Christina Hanzis, Sigitas Verselis, PhD, Lian Xu, Zachary Hunter, Leukothea Ioakimidis, Patricia Sheehy, NP, Christopher Patterson, Edward Fox, PhD, Steven P. Treon, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 4904.
https://doi.org/10.1182/blood.V116.21.4904.4904
Published: 2010
Journal Articles

Identification of Potential Therapeutic Targets Using Genome-Wide Analysis of Alternative Splicing (AS) In Patients with Acute Myeloid Leukemia (AML)

Free
Sophia Adamia, Hervé Avet-Loiseau, Laurence Lodé, Michal Bar-Natan, Sigitas Verselis, PhD, Edward Fox, Ilene Galinsky, ANP, Philippe Moreau, Richard Stone, MD, James D. Griffin, MD
Journal: Blood
Blood (2010) 116 (21): 177.
https://doi.org/10.1182/blood.V116.21.177.177
Published: 2010
Journal Articles

Polymorphisms of FcγRIIA, FcγRIIB, and FcγRIIIA and Therapeutic Response to Rituximab Combination Therapy in Patients with Waldenstrom's Macroglobulinemia.

Free
Guang Yang, PhD, Christina Hanzis, Ping Gong, Sigitas Verselis, PhD, Edward A. Fox, PhD, Lian Xu, Bryan Ciccarelli, Yangsheng Zhou, MD, PhD, Zachary Hunter, Jenny Sun, MD, Xia Liu, Hsiuyi Tseng, Yang Cao, Robert Manning, Megan Lewicki, Thea Ioakimidis, MS, Patricia Sheehy, NP, Christopher J Patterson, Steven Treon, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 2949.
https://doi.org/10.1182/blood.V114.22.2949.2949
Published: 2009
Journal Articles

Individuals Expressing FcγRIIIA-158 V/V and V/F Show Increased NK Cell Surface Expression of FcgRIIIA (CD16), Rituximab Binding, and Demonstrate Higher Levels of ADCC Activity in Response to Rituximab.

Free
Evdoxia Hatjiharissi, MD, Daniel Ditzel Santos, MD, Lian Xu, Sigitas Verselis, PhD, Michael Modica, PhD, Xavier Leleu, MD, Zachary Hunter, Allen W. Ho, Robert Manning, Christopher Patterson, Kenneth C. Anderson, MD, Edward Fox, PhD, Steven P. Treon, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 776.
https://doi.org/10.1182/blood.V106.11.776.776
Published: 2005
Journal Articles

Polymorphisms in Fc γ RIIIA Are Genetically Linked to FcγRIIA and May Account for the Primary Predictive Role Ascribed to Polymorphisms in FcγRIIIA-158 in Determining Rituximab Responses.

Free
Evdoxia Hatjiharissi, MD, Mark Hansen, Sigitas Verselis, PhD, Daniel Ditzel Santos, MD, Lian Xu, Robert Manning, Zachary Hunter, Xavier Leleu, MD, Allen W. Ho, Christopher J. Patterson, Edward Fox, PhD, Steven P. Treon, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 2433.
https://doi.org/10.1182/blood.V106.11.2433.2433
Published: 2005